EIDD-1723

From WikiMD's Wellness Encyclopedia

Error creating thumbnail:
EIDD-1723


EIDD-1723 is an antiviral drug candidate that is being developed for the treatment of COVID-19. It is a prodrug of the active compound EIDD-2801, which is metabolized in the body to N4-hydroxycytidine, a nucleoside analog that inhibits viral RNA polymerase.

History[edit | edit source]

EIDD-1723 was first synthesized by researchers at Emory University's Drug Innovation Ventures (DRIVE). The compound was later licensed to Ridgeback Biotherapeutics, a Miami-based biotechnology company, for further development and clinical testing.

Mechanism of Action[edit | edit source]

EIDD-1723 works by introducing copying errors into the viral genome during replication. The active metabolite, N4-hydroxycytidine, is incorporated into the viral RNA by the viral RNA polymerase. This causes a high rate of mutation in the viral genome, leading to a phenomenon known as "error catastrophe" or "lethal mutagenesis".

Clinical Trials[edit | edit source]

In 2020, EIDD-1723 entered Phase 1 clinical trials for safety and pharmacokinetics in healthy volunteers. The drug is also being tested in animal models for efficacy against a range of viruses, including SARS-CoV-2, the virus that causes COVID-19.

Potential Applications[edit | edit source]

In addition to its potential use in treating COVID-19, EIDD-1723 may also have applications in the treatment of other viral diseases. Preclinical studies have shown that the drug has broad-spectrum antiviral activity against a range of RNA viruses, including influenza, Ebola, and coronaviruses.

See Also[edit | edit source]


Resources[edit source]

Latest articles - EIDD-1723

PubMed
Clinical trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on EIDD-1723 for any updates.



WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD